The social and cultural construction of psychiatric knowledge: An analysis of NICE guidelines on depression and ADHD

Anthropology and Medicine

Volumn 20, Issue 1, 2013, Pages 59-71

  Moncrieff, Joanna ^a   Timimi, Sami ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LINCOLNSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ADHD; clinical guidelines; depression; evidence based medicine; sociology of knowledge

Indexed keywords

CENTRAL STIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; CONCEPT FORMATION; CONFLICT OF INTEREST; CONSENSUS DEVELOPMENT; CULTURAL FACTOR; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; KNOWLEDGE MANAGEMENT; PHILOSOPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCIENCE; SOCIAL ASPECT; VALIDITY;

ANTHROPOLOGY, MEDICAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CULTURE; DEPRESSION; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL HEALTH SERVICES; PRACTICE GUIDELINES AS TOPIC; SOCIAL VALUES;

EID: 84876470725     PISSN: 13648470     EISSN: 14692910     Source Type: Journal    
DOI: 10.1080/13648470.2012.747591     Document Type: Article

References (53)

1. Barkley, R.A., M. Fischer, L. Smallish, and K. Fletcher. 2004. Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry 45, no. 2: 195-211. (Pubitemid 38240269)
2. Biederman, J, S. Faraone, S. Milberger, J. Guite, E. Mick, L. Chen, et al. 1996. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Archives of General Psychiatry 53, no. 5: 437-46. (Pubitemid 26149233)
3. Biederman, J., E. Mick, C. Surman, R. Doyle, P. Hammerness, T. Harpold et al. 2006. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry 59, no. 9: 829-35.
4. Breggin, P. 2001. Talking back to ritalin. What doctors aren't telling you about stimulants and ADHD. Cambridge, MA: Perseus Publishing.
5. Conrad, P. 2009. Medicalization and social control. Annual Review of Sociology 18: 209-32.
6. Conrad, P., and D. Potter. 2000. From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems 47, no. 4: 559-82. (Pubitemid 33231713)
7. De Vries, R., and T. Lemmens. 2006. The social and cultural shaping of medical evidence: case studies from pharmaceutical research and obstetric science. Social Science and Medicine 62, no. 11: 2694-706. (Pubitemid 44389402)
8. Dowrick, C. 2004. Beyond depression: A new approach to understanding and management. Oxford: Oxford University Press.
9. Dulcan, M.K., and R.S. Benson. 1997. AACAP official action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 36, no. 9: 1311-17. (Pubitemid 27381291)
10. Faraone, S.V., J. Biederman, and E. Mick. 2006. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 36, no. 2: 159-65. (Pubitemid 43126140)
11. Faravelli, C., P. Servi, J.A. Arends, and W.K. Strik. 1996. Number of symptoms, quantification, and qualification of depression. Comprehensive Psychiatry 37, no. 5: 307-15. (Pubitemid 26304775)
12. Fergusson, D.M., L.J. Horwood, and E.M. Ridder. 2007. Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug and Alcohol Dependence 88 Suppl 1: S14-26. (Pubitemid 46282352)
13. Feyerabend, P. 1975. Against method: Outline of an anarchistic theory of knowledge. London: Verso.
14. Foucault, M. 1965. Madness and civilisation. London: Tavistock.
15. Foucault M. 2006. Psychiatric power. Lectures at the College de France 1973-1974. Basingstoke: Palgrave Macmillan.
16. Frick, P.J., R.W. Kamphaus, B.B. Lahey, R. Loeber, M.A. Christ, E.L. Hart, et al. 1991. Academic underachievement and the disruptive behavior disorders. Journal of Consulting and Clinical Psychology 59, no. 2: 289-94.
17. Goldenberg, M.J. 2006. On evidence and evidence-based medicine: lessons from the philosophy of science. Social Science and Medicine 62, no. 11: 2621-32.
18. Harris, G., and B. Carey. 2008. Researchers fail to reveal full drug pay. New York Times June 8.
19. Harrison, S. 1996. The politics of evidence-based medicine in the United Kingdom. Policy and Politics 26: 15-31.
20. Healy, D. 2006. Manufacturing consensus. Culture, Medicine and Psychiatry 30, no. 2: 135-56. (Pubitemid 44326865)
21. Information Centre for Health and Social Care. 2009. Prescription Cost Analysis 2008. London, NHS Information Centre.
22. Jenkings, K.N., and N. Barber. 2004. What constitutes evidence in hospital new drug decision making? Social Science and Medicine 58, no. 9: 1757-66. (Pubitemid 38281141)
23. Jensen, P.S., D. Martin, and D.P. Cantwell. 1997. Comorbidity in ADHD: Implications for research, practice, and DSM-V. Journal of the American Academy of Child and Adolescent Psychiatry 36, no. 8: 1065-79. (Pubitemid 27337657)
24. Jensen, P.S., Arnold, L.E., Swanson, J.M. Vitiello B, Abikoff HB, Greenhill LL et al. 2007. 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry 46, no. 8: 989-1002. (Pubitemid 47220683)
25. Joseph, J. 2003. The Gene Illusion: genetic research in psychiatry and psychology under the microscope. Ross-on-Wye: PCCS Books.
26. Kessler, R.C., L. Adler, R. Barkley, J. Biederman, C.K. Conners, O. Demler et al. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163, no. 4: 716-23. (Pubitemid 44464584)
27. King, S., S. Griffin, Z. Hodges, H. Weatherly, C. Asseburg, G. Richardson, et al. 2006. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technology Assessment 10, no. 23: iii-146.
28. Kirsch, I., and J. Moncrieff. 2007. Clinical trials and the response rate illusion. Contemporary Clinical Trials 28: 348-51. (Pubitemid 46755021)
29. Koesters, M., T. Becker, R. Kilian, J.M. Fegert, and S. Weinmann. 2008. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. Journal of Psychopharmacology. doi: 10.1177/0269881108092338
30. Kooij, J.J., H. Burger, A.M. Boonstra, P.D. Van der Linden, L.E. Kalma, J.K. Buitelaar. 2004. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine 34, no. 6: 973-82. (Pubitemid 39199967)
31. Kuhn, T.S. 1970. The structure of scientific revolutions. 2nd ed. Chicago: University of Chicago Press.
32. Lambert, H. 2006. Accounting for EBM: notions of evidence in medicine. Social Science and Medicine 62, no. 11: 2633-45.
33. Landsman, G.H. 2006. What evidence, whose evidence?: Physical therapy in New York State's clinical practice guideline and in the lives of mothers of disabled children. Social Science and Medicine 62, no. 11: 2670-80.
34. Latour, B. 1987. Science in action: How to follow scientists and engineers through society. Cambridge, MA: Harvard University Press.
35. Lead Discovery. 2004. Adult ADHD-therapeutic opportunities. Lead Discovery (cited 2009 April 17); Available from: https://www.leaddiscovery.co. uk/reports/813/Adult-ADHD-herapeutic-Opportunities.
36. Lee, S.S., and S.P. Hinshaw. 2004. Severity of adolescent delinquency among boys with and without attention deficit hyperactivity disorder: predictions from early antisocial behavior and peer status. Journal of Clinical Child and Adolescent Psychology 33, no. 4: 705-16. (Pubitemid 39614982)
37. Mannuzza, S., R.G. Klein, H. Abikoff, J.L. Moulton III. 2004. Significance of childhood conduct problems to later development of conduct disorder among children with ADHD: A prospective follow-up study. Journal of Abnormal Child Psychology 32, no. 5: 565-73. (Pubitemid 39158513)
38. Moncrieff, J. 2008. The myth of the chemical cure: A critique of psychiatric drug treatment. Basingstoke: Palgrave Macmillan.
39. Moreira, T. 2005. Diversity in clinical guidelines: the role of repertoires of evaluation. Social Science and Medicine 60, no. 9: 1975-85. (Pubitemid 40311718)
40. National Institute for Health and Clinical Excellence. 2004. Depression: Management of depression in primary and secondary care. Clinical practice guideline Number 23. London: National Institute for Clinical Excellence.
41. National Institute for Health and Clinical Excellence. 2008a. Attention Deficit Hyperactivity Disorder. Diagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72. London: National Institute for Clinical Excellence.
42. National Institute for Health and Clinical Excellence. 2008b. Response to comments on ADHD draft guidelines.
43. National Institute for Health and Clinical Excellence. 2009. Depression: Management of depression in primary and secondary care. Revised clinical practice guideline Number 23. London: National Institute for Health and Clinical Excellence.
44. Pickering, A.E. 1992. Science as practice and culture. Chicago: University of Chicago Press.
45. Pilgrim, D., and R.P. Bentall. 1999. The medicalisation of misery: A critical realist analysis of the concept of depression. Journal of Mental Health 8: 261-74. (Pubitemid 29305579)
46. Price, T.S., E. Simonoff, P. Asherson, S. Curran, J. Kuntsi, I. Waldman, et al. 2005. Continuity and change in preschool ADHD symptoms: Longitudinal genetic analysis with contrast effects. Behav Genet 35, no. 2: 121-32. (Pubitemid 40645674)
47. Proctor, R.N. 1991. Value-free science? Purity and power in modern knowledge. Cambridge, MA: Harvard University Press.
48. Santosh, P., E. Taylor, J. Swanson, et al. 2005. Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clinical Neuroscience Research 5: 307-14. (Pubitemid 43024823)
49. Schachter, H.M., B. Pham, J. King, S. Langford, and D. Moher. 2001. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal 165, no. 11: 1475-88. (Pubitemid 34060190)
50. Spencer, T., J. Biederman, T. Wilens, R. Doyle, C. Surman, J. Prince, et al. 2005. A large, doubleblind, randomized clinical trial of methylphenidate in the treatment of adults with attentiondeficit/hyperactivity disorder. Biological Psychiatry 57, no. 5: 456-63. (Pubitemid 40311979)
51. Sondeijker, F.E., R.F. Ferdinand, A.J. Oldehinkel, R. Veenstra, A.F. De Winter, J. Ormel, et al. 2005. Classes of adolescents with disruptive behaviors in a general population sample. Social Psychiatry and Psychiatric Epidemiology 40, no. 11: 931-8. (Pubitemid 41662423)
52. van Lier, P.A., E.J. Verhulst, J. van der Ende, and A.A. Crijnen. 2003. Classes of disruptive behaviour in a sample of young elementary school children. Journal of Child Psychology and Psychiatry 44, no. 3: 377-87. (Pubitemid 36943972)
53. World Health Organisation. 1990. International classification of diseases, version 10. Geneva: World Health Organisation.